Literature DB >> 17479186

Chemokines as mediators of angiogenesis.

Borna Mehrad1, Michael P Keane, Robert M Strieter.   

Abstract

Chemokines were originally described as cytokines that mediate leukocyte recruitment to sites of inflammation. Members of a subgroup of chemokines, the CXC family, also play a critical role in both physiologic and pathologic angiogenesis, including in the context of chronic inflammation, fibrosis, and malignancy. A unique feature of this family of cytokines is that, on the basis of their structure and receptor binding, individual ligands display either angiogenic or angiostatic biological activity in the regulation of angiogenesis. In this review, we summarize the key literature in this growing field.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479186      PMCID: PMC3353527     

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  133 in total

1.  Chemokine/chemokine receptor nomenclature.

Authors: 
Journal:  Cytokine       Date:  2003-01-07       Impact factor: 3.861

2.  CCL16 activates an angiogenic program in vascular endothelial cells.

Authors:  Marina Strasly; Gabriella Doronzo; Paola Cappello; Paola Capello; Donatella Valdembri; Marco Arese; Stefania Mitola; Paul Moore; Giulio Alessandri; Mirella Giovarelli; Federico Bussolino
Journal:  Blood       Date:  2003-09-04       Impact factor: 22.113

3.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.

Authors:  Roderick J Phillips; Marie D Burdick; Marin Lutz; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  Am J Respir Crit Care Med       Date:  2003-03-05       Impact factor: 21.405

4.  Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis.

Authors:  Arkadiusz Z Dudek; Irina Nesmelova; Kevin Mayo; Catherine M Verfaillie; Simon Pitchford; Arne Slungaard
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

5.  Identification of genes promoting angiogenesis in mouse lung by transcriptional profiling.

Authors:  Sorachai Srisuma; Shyam S Biswal; Wayne A Mitzner; Sandra J Gallagher; Kim H Mai; Elizabeth M Wagner
Journal:  Am J Respir Cell Mol Biol       Date:  2003-02-14       Impact factor: 6.914

6.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.

Authors:  Patrick M Winter; Anne M Morawski; Shelton D Caruthers; Ralph W Fuhrhop; Huiying Zhang; Todd A Williams; John S Allen; Elizabeth K Lacy; J David Robertson; Gregory M Lanza; Samuel A Wickline
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

7.  Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.

Authors:  Michael P Keane; John A Belperio; Ying Y Xue; Marie D Burdick; Robert M Strieter
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

8.  Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB.

Authors:  Badar M Mian; Colin P N Dinney; Carlos E Bermejo; Paul Sweeney; Carmen Tellez; X D Yang; Jean M Gudas; David J McConkey; Menashe Bar-Eli
Journal:  Clin Cancer Res       Date:  2003-08-01       Impact factor: 12.531

9.  The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.

Authors:  Igor Garkavtsev; Sergey V Kozin; Olga Chernova; Lei Xu; Frank Winkler; Edward Brown; Gene H Barnett; Rakesh K Jain
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

10.  An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.

Authors:  Laura Lasagni; Michela Francalanci; Francesco Annunziato; Elena Lazzeri; Stefano Giannini; Lorenzo Cosmi; Costanza Sagrinati; Benedetta Mazzinghi; Claudio Orlando; Enrico Maggi; Fabio Marra; Sergio Romagnani; Mario Serio; Paola Romagnani
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  88 in total

Review 1.  Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report.

Authors:  Serpil Erzurum; Sharon I Rounds; Troy Stevens; Micheala Aldred; Jason Aliotta; Stephen L Archer; Kewal Asosingh; Robert Balaban; Natalie Bauer; Jahar Bhattacharya; Harm Bogaard; Gaurav Choudhary; Gerald W Dorn; Raed Dweik; Karen Fagan; Michael Fallon; Toren Finkel; Mark Geraci; Mark T Gladwin; Paul M Hassoun; Marc Humbert; Naftali Kaminski; Steven M Kawut; Joseph Loscalzo; Donald McDonald; Ivan F McMurtry; John Newman; Mark Nicolls; Marlene Rabinovitch; Judy Shizuru; Masahiko Oka; Peter Polgar; David Rodman; Paul Schumacker; Kurt Stenmark; Rubin Tuder; Norbert Voelkel; Eugene Sullivan; Richard Weinshilboum; Mervin C Yoder; Yingming Zhao; Dorothy Gail; Timothy M Moore
Journal:  Am J Respir Crit Care Med       Date:  2010-09-10       Impact factor: 21.405

Review 2.  Chemokine Involvement in Fetal and Adult Wound Healing.

Authors:  Swathi Balaji; Carey L Watson; Rajeev Ranjan; Alice King; Paul L Bollyky; Sundeep G Keswani
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 3.  Chemokines as mediators of tumor angiogenesis and neovascularization.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Exp Cell Res       Date:  2010-10-30       Impact factor: 3.905

4.  Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels.

Authors:  Serena Vettori; Giovanna Cuomo; Michele Iudici; Virginia D'Abrosca; Veronica Giacco; Giusi Barra; Raffaele De Palma; Gabriele Valentini
Journal:  J Clin Immunol       Date:  2014-04-24       Impact factor: 8.317

Review 5.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

6.  Association between preeclampsia and the CXC chemokine family (Review).

Authors:  Xijing Liu; L I Dai; Rong Zhou
Journal:  Exp Ther Med       Date:  2015-03-09       Impact factor: 2.447

Review 7.  The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.

Authors:  Sandra M Cardona; Jenny A Garcia; Astrid E Cardona
Journal:  Methods Mol Biol       Date:  2013

8.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis.

Authors:  Stacy J Park; Molly A Hughes; Marie Burdick; Robert M Strieter; Borna Mehrad
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 10.  Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?

Authors:  Carlo Chizzolini; Jean-Michel Dayer; Pierre Miossec
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.